- Home
- MRNA vs OWL Comparison
MRNA vs OWL Comparison
Compare MRNA & OWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- OWL
- Stock Information
- Founded
- MRNA 2010
- OWL 2020
- Country
- MRNA United States
- OWL United States
- Employees
- MRNA N/A
- OWL N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- OWL Investment Managers
- Sector
- MRNA Health Care
- OWL Finance
- Exchange
- MRNA Nasdaq
- OWL Nasdaq
- Market Cap
- MRNA 9.8B
- OWL 10.6B
- IPO Year
- MRNA 2018
- OWL N/A
- Fundamental
- Price
- MRNA $25.18
- OWL $16.12
- Analyst Decision
- MRNA Hold
- OWL Buy
- Analyst Count
- MRNA 15
- OWL 16
- Target Price
- MRNA $37.15
- OWL $22.73
- AVG Volume (30 Days)
- MRNA 10.8M
- OWL 14.1M
- Earning Date
- MRNA 11-06-2025
- OWL 10-30-2025
- Dividend Yield
- MRNA N/A
- OWL 5.71%
- EPS Growth
- MRNA N/A
- OWL N/A
- EPS
- MRNA N/A
- OWL 0.02
- Revenue
- MRNA $3,078,000,000.00
- OWL $2,745,943,000.00
- Revenue This Year
- MRNA N/A
- OWL $17.23
- Revenue Next Year
- MRNA $11.12
- OWL $21.81
- P/E Ratio
- MRNA N/A
- OWL $470.74
- Revenue Growth
- MRNA N/A
- OWL 27.24
- 52 Week Low
- MRNA $23.15
- OWL $14.55
- 52 Week High
- MRNA $56.70
- OWL $26.73
- Technical
- Relative Strength Index (RSI)
- MRNA 44.51
- OWL 43.33
- Support Level
- MRNA $24.25
- OWL $15.37
- Resistance Level
- MRNA $29.20
- OWL $17.17
- Average True Range (ATR)
- MRNA 1.50
- OWL 0.63
- MACD
- MRNA -0.13
- OWL 0.00
- Stochastic Oscillator
- MRNA 16.97
- OWL 34.95
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.